Navigation Links
Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer
Date:11/5/2009

ombination with oxaliplatin-based chemotherapy, including known events such as rash, diarrhea and hypomagnesemia. Vectibix-related grade 3 infusion reactions were reported for two patients (less than 1 percent).

Originally designed to compare the treatment effect in the overall population, the study was amended to analyze outcomes with respect to the presence or absence of activating mutations in KRAS in the tumor itself. Tumor KRAS status was ascertained in more than 90 percent of the 1,183 patients enrolled in the trial.

Available results from the trial were presented earlier this year at the 2009 ECCO 15 - ESMO 34 European Multidisciplinary Congress in Berlin, Germany showing that Vectibix significantly improved median progression-free survival by 1.6 months (9.6 versus 8.0 months for patients treated with FOLFOX alone, in patients with KRAS wild-type mCRC (primary endpoint). Further, the addition of Vectibix to chemotherapy also improved response rate in the KRAS wild-type patient population as measured by blinded central review (55 percent versus 48 percent in the FOLFOX only arm).

The data for the 203 study has been submitted for consideration of presentation at the American Society of Clinical Oncology - The Gastrointestinal Cancers Symposium Meeting for 2010.

Study Design

Patients enrolled in the "203" or PRIME trial (Panitumumab Randomized trial in combination with chemotherapy for Metastatic colorectal cancer to determine Efficacy) were randomized to receive either 6.0 mg/kg of Vectibix and FOLFOX4 once every two weeks (Q2W) or FOLFOX4 alone Q2W. The primary endpoint of the study is progression-free survival by KRAS status and secondary endpoints include overall survival, objective response rate, time to progression, duration of response and safety.

About KRAS

Results from studies performed over the last twenty-five y
'/>"/>

SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Call for Applications: The Amgen Award for Science Teaching Excellence
2. Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
3. Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes
4. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
5. Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
6. CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
7. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
8. AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform
9. Medarex to Receive Milestone Payment from Amgen
10. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
11. Reminder Webcast Alert: Transgenomic, Inc. Announces Third Quarter 2009 Earnings Release Conference Call Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... May 21, 2015  Cardica, Inc. (Nasdaq: CRDC ) ... Greg Watson , the company,s vice president of operations, was ... common stock, at a per share exercise price of $0.43, ... option was granted pursuant to Cardica, Inc.,s Inducement Plan, which ... 2015 under Rule 5653(c)(4) of the Nasdaq Global Market for ...
(Date:5/21/2015)... The Pharmaceutical Care Management Association (PCMA) ... D offsets included in the Energy & Commerce ... the 21st Century Cures initiative can only be advanced ... – Medicare – then its costs outweigh any ... "Leveraging payments to Part D plans ...
(Date:5/21/2015)... , May 21, 2015 ... Arzneimittelfälschungen - Zwecks Leistungsvergleich zur Expertise ... auf EG-Mitgliedstaaten verwiesen, in denen uneingeschränkt ... Wählen Sie ein Aegate-Land: beispielsweise BELGIEN ... zur Bekämpfung von Arzneimittelfälschungen (FMD) handelt ...
Breaking Medicine Technology:Cardica Announces New Employment Inducement Grant 2EU-Arzneimittel-Richtlinie für gefälschte Medikamente; Aegate-Zusammenfassung als reale Bewertung aus Belgien 2EU-Arzneimittel-Richtlinie für gefälschte Medikamente; Aegate-Zusammenfassung als reale Bewertung aus Belgien 3
... SPRING, Md., Dec. 14, 2010 The U.S. Food and ... (benzonatate) by children younger than 10 years can result ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) Tessalon, approved by ... patients older than 10, may attract younger children because ...
... 2010 Reportlinker.com announces that a new market research ... U.S. Market for Patient Monitoring Devices 2011 ... the U.S. patient monitoring market was valued at $3 ... The market for patient monitoring devices includes: ...
Cached Medicine Technology:FDA Says Tessalon Liquid Cough Capsules Pose Risk for Young Children 2Reportlinker Adds U.S. Market for Patient Monitoring Devices 2011 2Reportlinker Adds U.S. Market for Patient Monitoring Devices 2011 3Reportlinker Adds U.S. Market for Patient Monitoring Devices 2011 4Reportlinker Adds U.S. Market for Patient Monitoring Devices 2011 5Reportlinker Adds U.S. Market for Patient Monitoring Devices 2011 6Reportlinker Adds U.S. Market for Patient Monitoring Devices 2011 7Reportlinker Adds U.S. Market for Patient Monitoring Devices 2011 8Reportlinker Adds U.S. Market for Patient Monitoring Devices 2011 9Reportlinker Adds U.S. Market for Patient Monitoring Devices 2011 10Reportlinker Adds U.S. Market for Patient Monitoring Devices 2011 11Reportlinker Adds U.S. Market for Patient Monitoring Devices 2011 12Reportlinker Adds U.S. Market for Patient Monitoring Devices 2011 13Reportlinker Adds U.S. Market for Patient Monitoring Devices 2011 14Reportlinker Adds U.S. Market for Patient Monitoring Devices 2011 15Reportlinker Adds U.S. Market for Patient Monitoring Devices 2011 16Reportlinker Adds U.S. Market for Patient Monitoring Devices 2011 17Reportlinker Adds U.S. Market for Patient Monitoring Devices 2011 18Reportlinker Adds U.S. Market for Patient Monitoring Devices 2011 19Reportlinker Adds U.S. Market for Patient Monitoring Devices 2011 20
(Date:5/22/2015)... May 22, 2015 The American College ... events in June. They will hold a webinar on ... a two-day class on Classical Chinese Medicine. , Webinar ... Dr. Steve Given, the Dean of Clinical Education, will ... new First Professional Doctorate program. ACTCM is currently developing ...
(Date:5/22/2015)... New York, New York (PRWEB) May 22, 2015 ... ( http://www.xareltolawsuit2015.com/ ) filed on behalf of individuals ... complications due to its use continue to move ... of Louisiana. According to a Pretrial Order dated ... governing the preservation of documents and electronically stored ...
(Date:5/22/2015)... 22, 2015 Combination therapy, or ... for chronic obstructive pulmonary disorder (COPD) as the ... AstraZeneca plc as well as Germany’s Boehringer Ingelheim ... position. But will market payers, clinicians and patients ... products to completely new ones? , In spite ...
(Date:5/22/2015)... May 22, 2015 Family, friends, students, ... world-renowned surgical oncologist, Dr. LaSalle D. Leffall, on Monday, ... luncheon began after Grand Rounds in the hospital’s Tower ... anxiously outside the auditorium, trying to keep the secret. ... if he sees me, he’ll know something is up,” ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Memorial Day weekend ... Amica Insurance is offering some tips to help promote ... Council, there will be 383 traffic fatalities this Memorial Day ... the National Highway Traffic Safety Association: , ... the vehicle is wearing a seatbelt, whether they’re driving or ...
Breaking Medicine News(10 mins):Health News:ACTCM Announces Upcoming June Events 2Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 2Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 3Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 4Health News:Chronic Obstructive Pulmonary Disorder Therapeutics Market Discussed in In-demand FirstWord Report Published at MarketPublishers.com 2Health News:Colleagues Surprise Dr. LaSalle Leffall with 85th Birthday Celebration 2Health News:Amica Has 4 Road Safety Tips for Memorial Day Weekend 2
... (BALTIMORE, MD) Pneumonia kills more children around the ... effort to study the causes of childhood pneumonia across ... a groundbreaking new study called the Pneumonia Etiology Research ... A collaboration between 5 African and 2 Asian research ...
... TUESDAY, Aug. 16 (HealthDay News) -- Drinking moderate amounts ... dementia, according to a review of previous research. ... Medicine analyzed data from more than 365,000 people who ... 1977. Moderate drinkers were 23 percent less likely ...
... professor at the School of Public Health and Information ... just 21 Robert Wood Johnson Foundation (RWJF) Executive Nurse ... nurse leaders from across the country chosen to participate ... enhance nurse leaders, effectiveness in improving the United States ...
... -- Taiwanese who exercise for 15 minutes a day, or ... years compared to people who are inactive, according to a ... at very light levels reduced deaths from any cause by ... professor and chair of The University of Texas MD Anderson ...
... , MONDAY, Aug. 15 (HealthDay News) -- During a firefight in ... a live grenade and threw it away to save the lives ... off his right hand. A bleeding Petry, who,d also been shot ... "He probably saved his own life by doing it," said ...
... nut-allergy sufferers face hostility and scepticism in trying to find ... Researchers found that parents are routinely made to feel ... is a ,frivolous and self indulgent fad invented and maintained ... they were bullied by classmates saying, "I,ve got nuts and ...
Cached Medicine News:Health News:Largest global childhood pneumonia etiology study launched 2Health News:Largest global childhood pneumonia etiology study launched 3Health News:Moderate Drinking May Help Prevent Alzheimer's, Other Dementia 2Health News:Moderate Drinking May Help Prevent Alzheimer's, Other Dementia 3Health News:UofL's Ruth Carrico selected for National Nurse Fellowship 2Health News:UofL's Ruth Carrico selected for National Nurse Fellowship 3Health News:UofL's Ruth Carrico selected for National Nurse Fellowship 4Health News:Study finds 15 minutes of moderate daily exercise lengthens life 2Health News:Study finds 15 minutes of moderate daily exercise lengthens life 3Health News:New Strategy Trains All Soldiers in Trauma Care 2Health News:New Strategy Trains All Soldiers in Trauma Care 3Health News:New Strategy Trains All Soldiers in Trauma Care 4Health News:Nut-allergy sufferers face prejudice -- new study 2
A highly precise stereotactic radiosurgery system for the treatment of intra-cranial lesions....
The Radionics XKnife RT2 system provides a precise and versatile stereotactic radiation therapy solution....
The Primus linear accelerator is a fully digital, technologically advanced radiation therapy treatment delivery system. It can be configured for delivery of routine, 3-D conformal or IMRT treatments....
Clinac EX Platinum accelerators offer all the high performance features of the EX series and come standard with the latest high-precision dose sculpting technology for advanced tumor control....
Medicine Products: